However, there was data which revealed that paraoxonase activity could not independently predict cardiovascular outcome among non-dialysis CKD patients [114], and that the inverse association between PON1 activity and CVD risk was partly dependent on HDL-C levels [101], possibly suggesting that PON1 activity may have an auxiliary role for CVD risk assessment. This evidence concerns the gene PON1 and chronic kidney disease.